Bio-Techne Corp. TECH recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

近期，Bio-Techne Corp（NASDAQ:TECH）董事Amy E. Herr进行了一笔股票交易。在2025年2月14日，她以平均每股$65.96的价格出售了总值$122,690的股票。此次交易后，Herr在公司的直接持股量为1,040股。根据 InvestingPro 数据显示，该公司股票目前接近52周低点$61.16，分析师给出的目标价区间为$75至$95。

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...

Baird R W lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a strong-buy rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports. Several other research ...

Herr博士的任命标志着Bio-Techne董事会为期两年寻找退休成员继任者的工作圆满完成。Bio-Techne总裁兼首席执行官Kim Kelderman对Herr博士在生物学和工程学方面的深厚经验与公司战略方向的契合表示热切期待。董事会主席Bob Baumgartner也强调，随着公司蛋白质组学分析仪器业务的扩张，Herr博士在生物工程领域的丰富科学经验将为董事会带来宝贵价值。

Support from Generation X and Baby Boomers has put Nigel Farage’s Reform UK at the top of the Techne UK tracker poll for the first time ...

Chicago, for ‘The Bear,’ is depicted — accurately — as a place where the goal is not necessarily to win status or acclaim so ...

(RTTNews) - Bio-Techne (TECH), a US-based biotechnology company Thursday has introduced an expanded range of human and mouse RNAscope in situ hybridization probes to support spatial biology ...

MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope ...

Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral ...

Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Bio-Techne (NASDAQ:TECH – Get Free Report) was downgraded by stock analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report issued on Wednesday, Ratings reports. They ...